Australia | Part 2: Regulatory considerations for orphan drugs
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets out the key regulatory considerations in Australia. Orphan drug patent strategy...
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets...
Read More
Australia | Part 1: Patenting orphan drugs
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical products developed to treat rare diseases, however with each drug...
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical...
Read More
China | Draft changes to dual filing in China
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but this may be set to change. As noted in our article...
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but...
Read More
How divisional patent applications work in China
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines. For patent holders looking to secure their rights in China,...
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines....
Read More
Australia | NSW Government grant for startups and innovative SMEs
The MVP Ventures 2025–2026 Program offers innovators in New South Wales a valuable opportunity to take their products closer to market. For early-stage innovators with a developed Minimum Viable Product...
The MVP Ventures 2025–2026 Program offers innovators in New South Wales a valuable opportunity to take their products closer...
Read More
Breaking up is never easy – Brexit’s final bow
This year marks the final milestone of the Brexit trade mark transition.  After 31 December 2025, owners of an EU mark or a UK mark can no longer rely...
This year marks the final milestone of the Brexit trade mark transition.  After 31 December 2025, owners of an...
Read More
Singapore | IPOS revised fee schedule, changes to excess claim fees
The Intellectual Property Office of Singapore (IPOS) has announced upcoming revisions to its official fee schedule. Notably, the changes affect the threshold, calculation, and timing of excess claim fees...
The Intellectual Property Office of Singapore (IPOS) has announced upcoming revisions to its official fee schedule. Notably, the changes...
Read More
Australia | Utilising International Type Search to strengthen your IP strategy
Before diving into costly international patent applications, it's crucial to understand your options, and how to assess the viability of achieving a granted patent without overspending. This guide walks...
Before diving into costly international patent applications, it's crucial to understand your options, and how to assess the viability...
Read More
Latest statistics in the 2025 IP Australia Intellectual Property Report
IP Australia has released the thirteenth edition of the 'Australian Intellectual Property Report' (the Report) which presents key movements in IP statistics and explores the links between innovation, collaboration...
IP Australia has released the thirteenth edition of the 'Australian Intellectual Property Report' (the Report) which presents key movements...
Read More

Contact our Expert Team

Contact Us
Contact Us